Attentional and perceptual impairments in Parkinson's disease with visual hallucinations.

[1]  H. Vankova.  Mini Mental State , 2010 .

[2]  S. Houle,et al.  Serotonin 2A receptors and visual hallucinations in Parkinson disease. , 2010, Archives of neurology.

[3]  L. Shah,et al.  Functional magnetic resonance imaging. , 2010, Seminars in roentgenology.

[4]  I. Litvinenko,et al.  Use of Memantine (akatinol) for the Correction of Cognitive Impairments in Parkinson’s Disease Complicated by Dementia , 2010, Neuroscience and Behavioral Physiology.

[5]  E. Tolosa,et al.  Differential progression of brain atrophy in Parkinson's disease with and without visual hallucinations , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[6]  C. Tanner,et al.  Clinical features in early Parkinson disease and survival. , 2009, Archives of neurology.

[7]  F. Cornelissen,et al.  Impaired visual processing preceding image recognition in Parkinson's disease patients with visual hallucinations. , 2009, Brain : a journal of neurology.

[8]  R. Perneczky,et al.  Severity of neuropsychiatric symptoms and dopamine transporter levels in dementia with Lewy bodies: A 123I‐FP‐CIT SPECT study , 2009, Movement disorders : official journal of the Movement Disorder Society.

[9]  I. Bodis-Wollner.  Retinopathy in Parkinson disease , 2009, Journal of Neural Transmission.

[10]  Raffaele Dubbioso,et al.  Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's disease. , 2009, Brain : a journal of neurology.

[11]  W. Brouwer,et al.  The Effects of Apomorphine on Visual Perception in Patients With Parkinson Disease and Visual Hallucinations: A Pilot Study , 2009, Clinical neuropharmacology.

[12]  K. Jellinger,et al.  Formation and development of Lewy pathology: a critical update , 2009, Journal of Neurology.

[13]  Y. Saalmann,et al.  Gain control in the visual thalamus during perception and cognition , 2009, Current Opinion in Neurobiology.

[14]  T. Suhara,et al.  Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET , 2009, Neuroscience Research.

[15]  R. Walker,et al.  Non-motor symptoms in a prevalent population with Parkinson's disease in Tanzania. , 2009, Parkinsonism & related disorders.

[16]  K. Jellinger.  A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders. , 2009, Biochimica et biophysica acta.

[17]  E. Tolosa,et al.  Neuroanatomical substrate of visuospatial and visuoperceptual impairment in Parkinson's disease , 2009, Movement disorders : official journal of the Movement Disorder Society.

[18]  I. Bodis-Wollner,et al.  Inner retinal layer thinning in Parkinson disease. , 2009, Archives of ophthalmology.

[19]  C. Galletti,et al.  Human V6: The Medial Motion Area , 2009, Cerebral cortex.

[20]  Diane M. Beck,et al.  Top-down and bottom-up mechanisms in biasing competition in the human brain , 2009, Vision Research.

[21]  G. Stebbins,et al.  Hallucinations in Parkinson disease , 2009, Nature Reviews Neurology.

[22]  Urs P Mosimann,et al.  The retina in Parkinson's disease. , 2009, Brain : a journal of neurology.

[23]  C. White,et al.  Dopamine agonists in the treatment of early Parkinson's disease: a meta-analysis. , 2009, Parkinsonism & related disorders.

[24]  L. Defebvre,et al.  Motor‐related circuit dysfunction in MSA‐P: Usefulness of combined whole‐brain imaging analysis , 2009, Movement disorders : official journal of the Movement Disorder Society.

[25]  Lutz Jäncke,et al.  The Architecture of the Golfer's Brain , 2009, PloS one.

[26]  Glyn W. Humphreys,et al.  Impaired attentional selection following lesions to human pulvinar: Evidence for homology between human and monkey , 2009, Proceedings of the National Academy of Sciences.

[27]  Noriaki Hattori,et al.  Discrete parieto-frontal functional connectivity related to grasping. , 2009, Journal of neurophysiology.

[28]  J. P. Mayo.  Intrathalamic mechanisms of visual attention. , 2009, Journal of neurophysiology.

[29]  A. T. Smith,et al.  Dissociating vision and visual attention in the human pulvinar. , 2009, Journal of neurophysiology.

[30]  Carlos Falcón,et al.  Brain response to complex visual stimuli in Parkinson's patients with hallucinations: A functional magnetic resonance imaging study , 2008, Movement disorders : official journal of the Movement Disorder Society.

[31]  Jeonghun Ku,et al.  Brain mechanisms involved in processing unreal perceptions , 2008, NeuroImage.

[32]  Klaus Leonard Leenders,et al.  Visual object recognition and attention in Parkinson's disease patients with visual hallucinations , 2008, Movement disorders : official journal of the Movement Disorder Society.

[33]  R. Wurtz,et al.  Guarding the gateway to cortex: attention in visual thalamus , 2008, Nature.

[34]  Bogdan Draganski,et al.  Training-induced structural changes in the adult human brain , 2008, Behavioural Brain Research.

[35]  M. Catani,et al.  The arcuate fasciculus and the disconnection theme in language and aphasia: History and current state , 2008, Cortex.

[36]  C. Summerfield,et al.  A Neural Representation of Prior Information during Perceptual Inference , 2008, Neuron.

[37]  K. Nakashima,et al.  Executive dysfunction in non‐demented Parkinson’s disease patients with hallucinations , 2008, Acta neurologica Scandinavica.

[38]  Paul C. Fletcher,et al.  Separable Forms of Reality Monitoring Supported by Anterior Prefrontal Cortex , 2008, Journal of Cognitive Neuroscience.

[39]  I. Alafuzoff,et al.  Applicability of current staging/categorization of α-synuclein pathology and their clinical relevance , 2008, Acta Neuropathologica.

[40]  Y. Furiya,et al.  Increased temporal blood flow associated with visual hallucinations in Parkinson's disease with dementia , 2008, Movement disorders : official journal of the Movement Disorder Society.

[41]  A. Aleman,et al.  Hallucinations: The Science of Idiosyncratic Perception , 2008 .

[42]  Mary A. Peterson,et al.  Reduction in White Matter Connectivity, Revealed by Diffusion Tensor Imaging, May Account for Age-related Changes in Face Perception , 2008, Journal of Cognitive Neuroscience.

[43]  J. Parisi,et al.  Mesopontine cholinergic neuron involvement in Lewy body dementia and multiple system atrophy , 2008, Neurology.

[44]  J. Barnes,et al.  Executive functions are impaired in patients with Parkinson’s disease with visual hallucinations , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[45]  Z. Illés,et al.  Morphometric changes of gray matter in Parkinson's disease with depression: A voxel‐based morphometry study , 2008, Movement disorders : official journal of the Movement Disorder Society.

[46]  M. Mallar Chakravarty,et al.  The Connectivity of the Human Pulvinar: A Diffusion Tensor Imaging Tractography Study , 2007, Int. J. Biomed. Imaging.

[47]  P. Barone,et al.  A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations , 2007, Movement disorders : official journal of the Movement Disorder Society.

[48]  M. Bar,et al.  Magnocellular Projections as the Trigger of Top-Down Facilitation in Recognition , 2007, The Journal of Neuroscience.

[49]  Vesna Sossi,et al.  Dopamine transporter relation to dopamine turnover in Parkinson's disease: a positron emission tomography study , 2007, Annals of neurology.

[50]  Mark Hallett,et al.  Ideomotor apraxia: A review , 2007, Journal of the Neurological Sciences.

[51]  R N Henson,et al.  Mechanisms of top-down facilitation in perception of visual objects studied by FMRI. , 2007, Cerebral cortex.

[52]  P. Kempster,et al.  Patterns of levodopa response in Parkinson's disease: a clinico-pathological study. , 2007, Brain : a journal of neurology.

[53]  E. Tolosa,et al.  Cerebral atrophy in Parkinson's disease patients with visual hallucinations , 2007, European journal of neurology.

[54]  A. Ceballos-Baumann,et al.  Metabolic alterations in patients with Parkinson disease and visual hallucinations. , 2007, Archives of neurology.

[55]  John M. Ennis,et al.  A neurobiological theory of automaticity in perceptual categorization. , 2007, Psychological review.

[56]  L. Skipper,et al.  Pathogenic mutations in Parkinson disease , 2007, Human mutation.

[57]  Jerome M. Siegel,et al.  Hypocretin (orexin) cell loss in Parkinson’s disease , 2007, Brain : a journal of neurology.

[58]  G. Vingerhoets,et al.  Heterogeneity of Cognitive Dysfunction in Parkinson’s Disease: A Cohort Study , 2007, European Neurology.

[59]  Edgar Erdfelder,et al.  G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences , 2007, Behavior research methods.

[60]  E. Tolosa,et al.  Cognitive Changes in Parkinson’s Disease Patients with Visual Hallucinations , 2007, Dementia and Geriatric Cognitive Disorders.

[61]  V. Dhawan,et al.  Abnormal Metabolic Network Activity in Parkinson'S Disease: Test—Retest Reproducibility , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[62]  A. Dagher,et al.  Functional and Anatomical Magnetic Resonance Imaging in Parkinson’s Disease , 2007, Molecular Imaging and Biology.

[63]  B. M. de Jong,et al.  Medial versus lateral prefrontal dissociation in movement selection and inhibitory control , 2007, Brain Research.

[64]  David Eidelberg,et al.  Metabolic brain networks associated with cognitive function in Parkinson's disease , 2007, NeuroImage.

[65]  Jennifer A. Mangels,et al.  Visual search deficits in Parkinson's disease are attenuated by bottom-up target salience and top-down information , 2006, Neuropsychologia.

[66]  M. Oda,et al.  Hypoperfusion of the visual pathway in parkinsonian patients with visual hallucinations , 2006, Movement disorders : official journal of the Movement Disorder Society.

[67]  I. McKeith,et al.  Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.

[68]  Christian Büchel,et al.  Detecting fearful and neutral faces: BOLD latency differences in amygdala–hippocampal junction , 2006, NeuroImage.

[69]  D. Aarsland,et al.  A magnetic resonance imaging study of patients with Parkinson’s disease with mild cognitive impairment and dementia using voxel-based morphometry , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[70]  N. Kanwisher,et al.  Domain specificity in visual cortex. , 2006, Cerebral cortex.

[71]  Carme Junqué,et al.  Neuropsychological deficits in Parkinson's disease patients with visual hallucinations , 2006, Movement disorders : official journal of the Movement Disorder Society.

[72]  M. Duchowny,et al.  Orbitofrontal seizures presenting with ictal visual hallucinations and interictal psychosis. , 2006, Pediatric neurology.

[73]  Joseph B. Hopfinger,et al.  Interactions between endogenous and exogenous attention on cortical visual processing , 2006, NeuroImage.

[74]  Akiko Tamura,et al.  Impaired Visual Acuity as a Risk Factor for Visual Hallucinations in Parkinson’s Disease , 2006, Journal of geriatric psychiatry and neurology.

[75]  Elizabeth Littlewood,et al.  Characteristics of visual hallucinations in Parkinson disease dementia and dementia with lewy bodies. , 2006, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[76]  N. Bohnen,et al.  Cognitive correlates of cortical cholinergic denervation in Parkinson’s disease and parkinsonian dementia , 2006, Journal of Neurology.

[77]  S. Yantis,et al.  Selective visual attention and perceptual coherence , 2006, Trends in Cognitive Sciences.

[78]  E. Halgren,et al.  Top-down facilitation of visual recognition. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[79]  C. Goetz,et al.  Hallucinations in Parkinson disease in the prelevodopa era , 2006, Neurology.

[80]  H. Fukuyama,et al.  Regional cerebral blood flow in Parkinson disease with nonpsychotic visual hallucinations , 2005, Neurology.

[81]  R. Hilker,et al.  Dementia in Parkinson disease , 2005, Neurology.

[82]  E. Perry,et al.  Why people see things that are not there: A novel Perception and Attention Deficit model for recurrent complex visual hallucinations , 2005, Behavioral and Brain Sciences.

[83]  I. McKeith,et al.  Benefits of rivastigmine on attention in dementia associated with Parkinson disease , 2005, Neurology.

[84]  B. Schmand,et al.  Cognitive profile of patients with newly diagnosed Parkinson disease , 2005, Neurology.

[85]  Maria Fatima Silva,et al.  Independent patterns of damage within magno-, parvo- and koniocellular pathways in Parkinson's disease. , 2005, Brain : a journal of neurology.

[86]  D. Aarsland,et al.  A systematic review of prevalence studies of dementia in Parkinson's disease , 2005, Movement disorders : official journal of the Movement Disorder Society.

[87]  David R Williams,et al.  Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study , 2005, The Lancet Neurology.

[88]  B. D. de Jong,et al.  Direct comparison between regional cerebral metabolism in progressive supranuclear palsy and Parkinson's disease , 2005, Movement disorders : official journal of the Movement Disorder Society.

[89]  S. Kastner,et al.  Stimulus context modulates competition in human extrastriate cortex , 2005, Nature Neuroscience.

[90]  Wiebo H Brouwer,et al.  Cognitive, physiological, and personality correlates of recurrence of depression. , 2005, Journal of affective disorders.

[91]  K. Bötzel,et al.  Prevalence and incidence of Parkinson's disease in Europe , 2005, European Neuropsychopharmacology.

[92]  Luigi Trojano,et al.  Frontal dysfunction contributes to the genesis of hallucinations in non‐demented Parkinsonian patients , 2005, International Journal of Geriatric Psychiatry.

[93]  A. Arditi.  Improving the design of the letter contrast sensitivity test. , 2005, Investigative ophthalmology & visual science.

[94]  A. Cronin-Golomb,et al.  Visual and spatial symptoms in Parkinson’s disease , 2005, Vision Research.

[95]  H. Braak,et al.  Cognitive status correlates with neuropathologic stage in Parkinson disease , 2005, Neurology.

[96]  Carol A. Seger,et al.  The Roles of the Caudate Nucleus in Human Classification Learning , 2005, The Journal of Neuroscience.

[97]  M. Carrasco,et al.  Transient Attention Enhances Perceptual Performance and fMRI Response in Human Visual Cortex , 2005, Neuron.

[98]  G. Stebbins,et al.  Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: Focused review and a new integrative model , 2005, Movement disorders : official journal of the Movement Disorder Society.

[99]  C. Summerfield,et al.  Structural brain changes in Parkinson disease with dementia: a voxel-based morphometry study. , 2005, Archives of neurology.

[100]  Alan C. Evans,et al.  Cerebral atrophy and its relation to cognitive impairment in Parkinson disease , 2005, Neurology.

[101]  S. Leurgans,et al.  Hallucinations and sleep disorders in PD , 2005, Neurology.

[102]  E. Tolosa,et al.  Comparative cognitive effects of bilateral subthalamic stimulation and subcutaneous continuous infusion of apomorphine in Parkinson's disease , 2004, Movement disorders : official journal of the Movement Disorder Society.

[103]  G. Glover,et al.  Altered cortical visual processing in PD with hallucinations , 2004, Neurology.

[104]  Lawrence C. Sincich,et al.  Bypassing V1: a direct geniculate input to area MT , 2004, Nature Neuroscience.

[105]  C. Peretz,et al.  Antiparkinsonian medication is not a risk factor for the development of hallucinations in Parkinson’s disease , 2004, Journal of Neural Transmission.

[106]  Hansjürgen Bratzke,et al.  Stages in the development of Parkinson’s disease-related pathology , 2004, Cell and Tissue Research.

[107]  Akinori Nakamura,et al.  Visual hallucination in Parkinson's disease with FDG PET , 2004, Movement disorders : official journal of the Movement Disorder Society.

[108]  E. Wolters,et al.  Cognitive dysfunction and dementia in Parkinson’s disease , 2004, Journal of Neural Transmission.

[109]  A. Revonsuo,et al.  Visual object recognition deficits in early Parkinson's disease. , 2004, Parkinsonism & related disorders.

[110]  Hugo Quené,et al.  On multi-level modeling of data from repeated measures designs: a tutorial , 2004, Speech Commun..

[111]  E. Wolters,et al.  Psychotic symptoms in Parkinson's disease: pathophysiology and management. , 2004, Expert opinion on drug safety.

[112]  I. McKeith,et al.  Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. , 2004, Brain : a journal of neurology.

[113]  Christian Wallraven,et al.  The role of characteristic motion in object categorization. , 2004, Journal of vision.

[114]  A M Stiggelbout,et al.  A short scale for the assessment of motor impairments and disabilities in Parkinson’s disease: the SPES/SCOPA , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[115]  Cheuk Y. Tang,et al.  Abnormal glucose metabolism in the mediodorsal nucleus of the thalamus in schizophrenia. , 2004, The American journal of psychiatry.

[116]  R. D. de Haan,et al.  Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD , 2004, Neurology.

[117]  N. Newman,et al.  Ophthalmologic features of Parkinson’s disease , 2004, Neurology.

[118]  Bogdan Draganski,et al.  Neuroplasticity: Changes in grey matter induced by training , 2004, Nature.

[119]  A. David,et al.  Reality monitoring and visual hallucinations in Parkinson’s disease , 2003, Neuropsychologia.

[120]  A M Stiggelbout,et al.  Assessment of cognition in Parkinson’s disease , 2003, Neurology.

[121]  S. Treue.  Climbing the cortical ladder from sensation to perception , 2003, Trends in Cognitive Sciences.

[122]  Lotfi B Merabet,et al.  Suppression of Complex Visual Hallucinatory Experiences by Occipital Transcranial Magnetic Stimulation: A Case Report , 2003, Neurocase.

[123]  A. Antonini,et al.  Continuous apomorphine infusion and neuropsychiatric disorders: a controlled study in patients with advanced Parkinson’s disease , 2003, Neurological Sciences.

[124]  A. Lees,et al.  Lewy body cortical involvement may not always predict dementia in Parkinson’s disease , 2003, Journal of neurology, neurosurgery, and psychiatry.

[125]  C. Goetz,et al.  Coping strategies for visual hallucinations in Parkinson's disease , 2003, Movement disorders : official journal of the Movement Disorder Society.

[126]  K. Grill-Spector.  The neural basis of object perception , 2003, Current Opinion in Neurobiology.

[127]  Takashi Kato,et al.  Occipital hypoperfusion in Parkinson’s disease without dementia: correlation to impaired cortical visual processing , 2003, Journal of neurology, neurosurgery, and psychiatry.

[128]  D. Aarsland,et al.  Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. , 2003, Archives of neurology.

[129]  B. Westerink,et al.  Can antipsychotic drugs be classified by their effects on a particular group of dopamine neurons in the brain? , 2002, European journal of pharmacology.

[130]  W. Burke,et al.  The neural basis of Charles Bonnet hallucinations: a hypothesis , 2002, Journal of neurology, neurosurgery, and psychiatry.

[131]  H. Przuntek,et al.  Apomorphine delays simple reaction time in Parkinsonian patients. , 2002, Parkinsonism & related disorders.

[132]  Yasushi Kobayashi,et al.  Sensory-motor gating and cognitive control by the brainstem cholinergic system , 2002, Neural Networks.

[133]  Karl J. Friston,et al.  The Neural Structures Expressing Perceptual Hysteresis in Visual Letter Recognition , 2002, Neuron.

[134]  M. Corbetta,et al.  Neural Systems for Visual Orienting and Their Relationships to Spatial Working Memory , 2002, Journal of Cognitive Neuroscience.

[135]  G. Halliday,et al.  Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. , 2002, Brain : a journal of neurology.

[136]  A. Paans,et al.  Brain Activation Related to the Representations of External Space and Body Scheme in Visuomotor Control , 2001, NeuroImage.

[137]  J. Colebatch,et al.  Motor imagery in Parkinson's disease: A PET study , 2001, Movement disorders : official journal of the Movement Disorder Society.

[138]  A. David,et al.  Visual hallucinations in Parkinson's disease: a review and phenomenological survey , 2001, Journal of neurology, neurosurgery, and psychiatry.

[139]  G. Wooten,et al.  Prospective study of hallucinations and delusions in Parkinson's disease , 2001, Journal of neurology, neurosurgery, and psychiatry.

[140]  Sanjay Mittal,et al.  4. 3D flows past circular cylinder of low aspect ratio , 2001 .

[141]  S. Schultz.  Principles of Neural Science, 4th ed. , 2001 .

[142]  M. Sarter,et al.  The cognitive neuroscience of sustained attention: where top-down meets bottom-up , 2001, Brain Research Reviews.

[143]  M. Bar,et al.  Cortical Mechanisms Specific to Explicit Visual Object Recognition , 2001, Neuron.

[144]  I Litvan,et al.  The FAB: A frontal assessment battery at bedside , 2000, Neurology.

[145]  O. Blanke,et al.  Electrical Cortical Stimulation of the Human Prefrontal Cortex Evokes Complex Visual Hallucinations , 2000, Epilepsy & Behavior.

[146]  Ravi S. Menon,et al.  The effects of visual object priming on brain activation before and after recognition , 2000, Current Biology.

[147]  Michael Aldrich,et al.  Reduced Number of Hypocretin Neurons in Human Narcolepsy , 2000, Neuron.

[148]  K. Grill-Spector,et al.  The dynamics of object-selective activation correlate with recognition performance in humans , 2000, Nature Neuroscience.

[149]  I G McKeith,et al.  Quantifying fluctuation in dementia with Lewy bodies, Alzheimer’s disease, and vascular dementia , 2000, Neurology.

[150]  G. Fénelon,et al.  Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. , 2000, Brain : a journal of neurology.

[151]  R. Raman,et al.  Decreased color discrimination and contrast sensitivity in Parkinson’s disease , 2000, Journal of the Neurological Sciences.

[152]  R. J. Seitz,et al.  A parieto-premotor network for object manipulation: evidence from neuroimaging , 1999, Experimental Brain Research.

[153]  E Stern,et al.  Mesolimbic Activity Associated with Psychosis in Schizophrenia: Symptom‐specific PET Studies , 1999, Annals of the New York Academy of Sciences.

[154]  S. Yamaguchi,et al.  Medication-induced hallucination and cerebral blood flow in Parkinson’s disease , 1999, Journal of Neurology.

[155]  Russell A. Epstein,et al.  The Parahippocampal Place Area Recognition, Navigation, or Encoding? , 1999, Neuron.

[156]  B. M. de Jong,et al.  Brain Activation Related to the Change between Bimanual Motor Programs , 1999, NeuroImage.

[157]  C H Lücking,et al.  Impairment in preattentive visual processing in patients with Parkinson's disease. , 1999, Brain : a journal of neurology.

[158]  D. Ffytche,et al.  The anatomy of conscious vision: an fMRI study of visual hallucinations , 1998, Nature Neuroscience.

[159]  C. Frith,et al.  Monitoring for target objects: activation of right frontal and parietal cortices with increasing time on task , 1998, Neuropsychologia.

[160]  A. Lang,et al.  Parkinson's disease. Second of two parts. , 1998, The New England journal of medicine.

[161]  Leslie G. Ungerleider,et al.  Mechanisms of directed attention in the human extrastriate cortex as revealed by functional MRI. , 1998, Science.

[162]  S. Leurgans,et al.  Poor visual discrimination and visual hallucinations in Parkinson's disease. , 1998, Clinical neuropharmacology.

[163]  C. Tanner,et al.  Early dopaminergic drug-induced hallucinations in parkinsonian patients , 1998, Neurology.

[164]  L. Rapport,et al.  Validation of the Warrington theory of visual processing and the Visual Object and Space Perception Battery. , 1998, Journal of clinical and experimental neuropsychology.

[165]  G. Stebbins,et al.  Intravenous levodopa in hallucinating Parkinson's disease patients , 1998, Neurology.

[166]  R. Turner,et al.  Event-Related fMRI: Characterizing Differential Responses , 1998, NeuroImage.

[167]  C D Frith,et al.  Space-based and object-based visual attention: shared and specific neural domains. , 1997, Brain : a journal of neurology.

[168]  Albert Gjedde,et al.  Cortical Sites of Sustained and Divided Attention in Normal Elderly Humans , 1997, NeuroImage.

[169]  N. Kanwisher,et al.  The Fusiform Face Area: A Module in Human Extrastriate Cortex Specialized for Face Perception , 1997, The Journal of Neuroscience.

[170]  H. Büning,et al.  Robust analysis of variance , 1997 .

[171]  P. Leigh,et al.  Use of apomorphine in parkinsonian patients with neuropsychiatric complications to oral treatment. , 1997, Parkinsonism & related disorders.

[172]  J. Sanchez-Ramos,et al.  Visual hallucinations associated with Parkinson disease. , 1996, Archives of neurology.

[173]  J. Mink.  THE BASAL GANGLIA: FOCUSED SELECTION AND INHIBITION OF COMPETING MOTOR PROGRAMS , 1996, Progress in Neurobiology.

[174]  P. Strick,et al.  The temporal lobe is a target of output from the basal ganglia. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[175]  B. M. de Jong,et al.  Brain activity related to serial cognitive performance resembles circuitry of higher order motor control , 1996, Experimental Brain Research.

[176]  R. Teunisse,et al.  Visual hallucinations in psychologically normal people: Charles Bonnet's syndrome , 1996, The Lancet.

[177]  K. Flowers,et al.  Perceptual Abnormalities in Parkinson's Disease: Top-Down or Bottom-Up Processes? , 1995, Perception.

[178]  R. Malach,et al.  Object-related activity revealed by functional magnetic resonance imaging in human occipital cortex. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[179]  E. Perry,et al.  Acetylcholine and Hallucinations - Disease-Related Compared to Drug-Induced Alterations in Human Consciousness , 1995, Brain and Cognition.

[180]  Karl J. Friston,et al.  Analysis of fMRI Time-Series Revisited , 1995, NeuroImage.

[181]  H. Przuntek,et al.  Distorted color discrimination in ‘de nova’ parkinsonian patients , 1995, Neurology.

[182]  C. Geula,et al.  Chemoarchitectonics of axonal and perikaryal acetylcholinesterase along information processing systems of the human cerebral cortex , 1994, Brain Research Bulletin.

[183]  Leslie G. Ungerleider,et al.  ‘What’ and ‘where’ in the human brain , 1994, Current Opinion in Neurobiology.

[184]  T. Yoshioka,et al.  A neurochemically distinct third channel in the macaque dorsal lateral geniculate nucleus. , 1994, Science.

[185]  J. Leysen,et al.  Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography , 1993, Brain Research.

[186]  G. Stebbins,et al.  Risk factors for nursing home placement in advanced Parkinson's disease , 1993, Neurology.

[187]  J. Calvert,et al.  Processing of spatial contrast in peripheral vision in Parkinson's disease. , 1992, Brain : a journal of neurology.

[188]  Richard S. J. Frackowiak,et al.  Impaired mesial frontal and putamen activation in Parkinson's disease: A positron emission tomography study , 1992, Annals of neurology.

[189]  S. Petersen,et al.  The pulvinar and visual salience , 1992, Trends in Neurosciences.

[190]  M. Corbetta,et al.  Selective and divided attention during visual discriminations of shape, color, and speed: functional anatomy by positron emission tomography , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[191]  T. Di Paolo,et al.  Decreased dopamine in the retinas of patients with Parkinson's disease. , 1990, Investigative ophthalmology & visual science.

[192]  D. LaBerge,et al.  Positron emission tomographic measurements of pulvinar activity during an attention task , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[193]  A. Lees,et al.  Subcutaneous apomorphine in the treatment of Parkinson's disease. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[194]  D. Turnbull,et al.  MITOCHONDRIAL FUNCTION IN PARKINSON'S DISEASE , 1989, The Lancet.

[195]  D L Price,et al.  The pedunculopontine nucleus in Parkinson's disease , 1989, Annals of neurology.

[196]  M. Raichle,et al.  Focal physiological uncoupling of cerebral blood flow and oxidative metabolism during somatosensory stimulation in human subjects. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[197]  E. Perry,et al.  Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease. , 1985, Journal of neurology, neurosurgery, and psychiatry.

[198]  F. Crick.  Function of the thalamic reticular complex: the searchlight hypothesis. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[199]  A. Laties,et al.  Dopaminergic neurons in the human retina , 1982, The Journal of comparative neurology.

[200]  H. Hacker,et al.  The significance of cerebral atrophy for the symptomatology of Parkinson's disease , 1979, Journal of the Neurological Sciences.

[201]  G. Selby.  Cerebral atrophy in Parkinsonism. , 1968, Journal of the neurological sciences.

[202]  A. Beck,et al.  An inventory for measuring depression. , 1961, Archives of general psychiatry.

[203]  C. D. Coryell,et al.  The Magnetic Properties and Structure of Hemoglobin, Oxyhemoglobin and Carbonmonoxyhemoglobin , 1936, Proceedings of the National Academy of Sciences.

[204]  Tiffany Hopkins,et al.  Hallucinations , 1908, The Hospital.

[205]  S. Haber,et al.  The Basal Ganglia , 2012 .

[206]  A. Meppelink.  Visual hallucinations in Parkinson's disease , 2011 .

[207]  E. Perry,et al.  Cholinergic and other neurotransmitter mechanisms in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies , 2007, Movement disorders : official journal of the Movement Disorder Society.

[208]  M. Steriade.  Acetylcholine systems and rhythmic activities during the waking--sleep cycle. , 2004, Progress in brain research.

[209]  Sabine Kastner,et al.  Functional imaging of the human lateral geniculate nucleus and pulvinar. , 2004, Journal of neurophysiology.

[210]  M. Mesulam,et al.  The cholinergic innervation of the human cerebral cortex. , 2004, Progress in brain research.

[211]  R. Marconi,et al.  Continuous apomorphine infusion (CAI) and neuropsychiatric disorders in patients with advanced Parkinson's disease: a follow-up of two years. , 2004, Archives of gerontology and geriatrics. Supplement.

[212]  M. Goodale,et al.  Two distinct modes of control for object-directed action. , 2004, Progress in brain research.

[213]  S Zeki,et al.  Localization and globalization in conscious vision. , 2001, Annual review of neuroscience.

[214]  W. Kuhn,et al.  Effects of apomorphine on visual functions in Parkinson's disease , 2000, Journal of Neural Transmission.

[215]  F. Andermann,et al.  REVIEW ARTICLE Complex visual hallucinations Clinical and neurobiological insights , 1998 .

[216]  D H Brainard,et al.  The Psychophysics Toolbox. , 1997, Spatial vision.

[217]  D G Pelli,et al.  The VideoToolbox software for visual psychophysics: transforming numbers into movies. , 1997, Spatial vision.

[218]  D. Rye.  Contributions of the pedunculopontine region to normal and altered REM sleep. , 1997, Sleep.

[219]  M Tagliati,et al.  The pattern electroretinogram in Parkinson's disease reveals lack of retinal spatial tuning. , 1996, Electroencephalography and clinical neurophysiology.

[220]  R. Desimone,et al.  Neural mechanisms of selective visual attention. , 1995, Annual review of neuroscience.

[221]  H. Przuntek,et al.  L-dopa improves colour vision in Parkinson's disease , 1994, Journal of neural transmission. Parkinson's disease and dementia section.

[222]  M. Tagliati,et al.  The visual system in Parkinson's disease. , 1993, Advances in neurology.

[223]  A. Lees.  Cognitive Deficits in Parkinson’s Disease , 1985 .